Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Metastatic × Cyclophosphamide × Breast × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 491 Triple Negative Breast Neoplasms 77 Inflammatory Breast Neoplasms 29 Breast Neoplasms, Male 26 Neoplasm Metastasis 23 Ovarian Neoplasms 21 Carcinoma, Non-Small-Cell Lung 21 Melanoma 20 Neoplasms 14 Pancreatic Neoplasms 13 Colorectal Neoplasms 12 Carcinoma, Renal Cell 11 Stomach Neoplasms 10 Multiple Myeloma 10 Lung Neoplasms 9 Carcinoma, Ovarian Epithelial 9 Lymphoma, Non-Hodgkin 8 Carcinoma, Hepatocellular 8 Sarcoma 7 Lymphoma, Follicular 7 Lymphoma 7 Recurrence 6 Neutropenia 6 Lymphoma, Mantle-Cell 6 Lymphoma, Large-Cell, Immunoblastic 6 Lymphoma, Large B-Cell, Diffuse 6 Lymphoma, B-Cell, Marginal Zone 6 Leukemia, Myeloid, Acute 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Kidney Neoplasms 6

Interventions

Fulvestrant 5 Letrozole 4 exemestane 3 Capecitabine 3 Anastrozole 3 ribociclib 2 dalpiciclib 2 apatinib 2 Trastuzumab 2 Gemcitabine 2 Docetaxel 2 tusamitamab ravtansine 1 trastuzumab deruxtecan 1 pyrotinib 1 patritumab deruxtecan 1 palbociclib 1 olaparib 1 nirogacestat 1 margetuximab 1 irinotecan sucrosofate 1 fluzoparib 1 abemaciclib 1 Zoledronic Acid 1 Vinorelbine 1 Tamoxifen 1 Paclitaxel 1 Neoadjuvant Therapy 1 Liposomes 1 Irinotecan 1 Ga(III)-DOTATOC 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04350021 2024-01-17

METRO

Vastra Gotaland Region

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡